Audio Recording of the Analysts/Investors Earnings Call for Unaudited Financial results of Quarter III of F.Y. 2024-25 ended on December 31, 2024 - Orchid Pharma Limited
Please find attached audio recording of Conference call for Analysts and Investors held today i.e. Wednesday, February 12, 2025 for Q3FY25 & 9MFY25 Results and Business Updates
Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached the transcript of the earnings conference call for the quarter ended December 31, 2024.